- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02488499
Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) (ABATE)
February 6, 2017 updated by: Brendan Andrade, Centre for Addiction and Mental Health
This study investigates the effectiveness of a clinic-adapted version of the Coping Power program compared to individualized child and family treatment for children with disruptive behaviour and their parents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This project compares the short- and long-term effectiveness of a clinic-adapted manualized group treatment (i.e., Coping Power; CP) to individualized child and family treatment for children aged 9 - 12 with disruptive behaviour.
Children and their parents who meet criteria and agree to participate in the project are randomly assigned to either the CP condition or the Individualized treatment condition.
In the CP condition, children and caregivers are asked to participate in two separate but complimentary 15-session groups.
Child groups target development of children's emotional and cognitive problem solving skills and caregiver groups facilitate cognitive and behavioural parenting skills.
In the Individualized treatment condition children and caregivers are asked to participate in 15 one-hour individual and family treatment sessions tailored by the clinician to address the children and parent's presenting concerns.
Measurement of behaviour and emotional functioning is done pre- post- and at 6-months following treatment.
Study Type
Interventional
Enrollment (Actual)
172
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6J 1H4
- Centre for Addiction and Mental Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 12 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parents provide free and informed consent and children assent to participate in the research, complete measures, and participate in either Coping Power or individualized treatment.
- Parents report symptoms consistent with clinical diagnoses of Oppositional Defiant Disorder or Conduct Disorder on the Diagnostic Interview Schedule for Children - DSM IV or parents and/or teacher report at or above a T-score of 60 (93rd percentile; borderline clinically severe range) on the Externalizing Behavior composite scale on the Behavior Assessment for Children - 2nd edition.
- Parents or teachers report clinically severe impairment in social, family, peer or overall functioning demonstrated by scores in the clinical range on the parent or teacher completed Impairment Rating Scale.
- The child's cognitive functioning is at or above a standard score of 80 (Borderline Range) on the verbal and/or nonverbal scales on the Kaufman Brief Intelligence Task - 2.
Exclusion Criteria:
- Evidence of Autism Spectrum Disorder or Asperger's Disorder as reported by parent, teacher or physician referral (if available).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Individualized Treatment
Individualized Treatment: 15 sessions of individualized treatment (i.e., parent-child) that target areas of presenting concern identified during assessment.
These may include social problem-solving, emotion regulation, parent-child difficulties.
|
15 sessions of individualized child and parent treatment
|
Experimental: Coping Power
Coping Power: 15 sessions of concurrent parent and child group treatment.
The child group focuses on developing problem-solving and emotion regulation skills.
The parent group focuses on developing parenting skills and problem-solving strategies to manage and reduce their children's disruptive behaviour.
|
15 sessions of concurrent parent and child group treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Conduct Problems scale score measured by the Strengths and Difficulties Questionnaire
Time Frame: Change from Baseline Conduct Problems at 15-weeks and at 6 months
|
Change from Baseline Conduct Problems at 15-weeks and at 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lochman JE, Powell N, Boxmeyer C, Andrade B, Stromeyer SL, Jimenez-Camargo LA. Adaptations to the coping power program's structure, delivery settings, and clinician training. Psychotherapy (Chic). 2012 Jun;49(2):135-42. doi: 10.1037/a0027165.
- Wells, K. C., Lochman, J. E., & Lenhart, L. A. (2008). Coping Power Parent Group Program: Facilitator Guide. New York: Oxford University Press.
- Wells, K. C., Lochman, J. E., & Lenhart, L. A. (2008b). Coping Power: Facilitators Guide. New York: Oxford Press
- Lochman JE, Wells KC. The coping power program for preadolescent aggressive boys and their parents: outcome effects at the 1-year follow-up. J Consult Clin Psychol. 2004 Aug;72(4):571-8. doi: 10.1037/0022-006X.72.4.571.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
June 24, 2015
First Submitted That Met QC Criteria
June 30, 2015
First Posted (Estimate)
July 2, 2015
Study Record Updates
Last Update Posted (Estimate)
February 8, 2017
Last Update Submitted That Met QC Criteria
February 6, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 091/2010-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disruptive Behavior Disorder
-
Washington University School of MedicineRecruitingDisruptive Behavior DisorderUnited States
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedDisruptive Behavior DisorderFinland
-
Christina StudtsUniversity of VermontCompletedParenting | Disruptive Behavior DisorderUnited States
-
IRCCS Fondazione Stella MarisUniversity of PisaCompletedAttention Deficit and Disruptive Behavior Disorders | Oppositional Defiant Disorder | Disruptive Behavior DisorderItaly
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)RecruitingExecutive Function | Disruptive Behavior | Disruptive Behavior Disorder, Childhood OnsetUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedPediatric Disruptive Behaviour DisorderCanada
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
Hospices Civils de LyonRecruitingClinical and Social Trajectories of Children and Adolescents With Disruptive Behavior (TRAJECTORIES)Disruptive Behavior DisorderFrance
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Clinical Trials on Individualized Treatment
-
China Academy of Chinese Medical SciencesNational Natural Science Foundation of ChinaUnknownSleep Initiation and Maintenance DisordersChina
-
Charite University, Berlin, GermanyAzienda Sanitaria de Sudtirol, Hospital Meran, Meran, ItalyCompleted
-
Universität Duisburg-EssenPoomulli Neelakandan Namboodiripad Memorial Ayurveda Medical CollegeUnknown
-
Karolinska InstitutetNorrbacka-Eugenia Foundation; Swedish Rheumatism Foundation; Svenska Diabetes...CompletedPsychosocial Treatment Intervention in Persons Newly Diagnosed With Rheumatoid Arthritis or DiabetesDiabetes Mellitus | Arthritis, Rheumatoid | Coping SkillsSweden
-
University of California, San FranciscoWashington University School of Medicine; University of Washington; Pacific Pediatric... and other collaboratorsRecruitingMedulloblastoma | Medulloblastoma, Childhood | Medulloblastoma RecurrentUnited States
-
Central Institute of Mental Health, MannheimUniversity of ZurichCompletedAggression | Conduct Disorder | Oppositional Defiant DisorderGermany, Switzerland
-
The Defense and Veterans Brain Injury CenterEvans Army Community HospitalActive, not recruitingTraumatic Brain Injury | Vestibular ProblemUnited States
-
RWTH Aachen UniversityWithdrawnInvasive Mechanical Ventilation | Severe Acute Respiratory Distress Syndrome / Severe ARDS | Individualized PEEP Treatment Strategy
-
Shanghai Zhongshan HospitalUnknownColorectal Cancer | Gastroesophageal Varices Hemorrhage | Received Oxaliplatin-based ChemotherapyChina
-
Colorado Center for Chronic Care Innovations, Inc.Microlife Medical Home Solutions, Inc.CompletedHypertension | ObesityUnited States